Susquehanna International Group, LLP Rhythm Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$40.81 - $55.0 $5.68 Million - $7.65 Million	139,100 Added 148.77%	232,600 $12.2 Million
Q2 2024 Aug 15, 2024	SELL	$35.41 - $44.37 $5.99 Million - $7.51 Million	-169,200 Reduced 64.41%	93,500 $3.84 Million
Q1 2024 May 07, 2024	SELL	$39.12 - $52.44 $324,696 - $435,252	-8,300 Reduced 3.06%	262,700 $11.4 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $4.7 Million - $10.9 Million	219,600 Added 427.24%	271,000 $12.5 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $262,446 - $461,480	16,600 Added 47.7%	51,400 $1.18 Million
Q2 2023 Aug 11, 2023	SELL	$16.32 - $21.15 $1.15 Million - $1.49 Million	-70,300 Reduced 66.89%	34,800 $573,000
Q1 2023 May 16, 2023	BUY	$16.88 - $34.24 $499,647 - $1.01 Million	29,600 Added 39.21%	105,100 $1.87 Million
Q4 2022 Feb 14, 2023	SELL	$22.21 - $30.25 $4.5 Million - $6.13 Million	-202,700 Reduced 72.86%	75,500 $2.2 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $724,550 - $5.2 Million	168,500 Added 153.6%	278,200 $6.82 Million
Q2 2022 Aug 15, 2022	BUY	$3.12 - $12.25 $16,224 - $63,700	5,200 Added 4.98%	109,700 $455,000
Q1 2022 May 16, 2022	BUY	$6.13 - $12.24 $294,240 - $587,520	48,000 Added 84.96%	104,500 $1.2 Million
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $990,756 - $1.53 Million	46,800 Added 482.47%	56,500 $1.68 Million
Q3 2020 Nov 16, 2020	BUY	$18.13 - $30.61 $175,861 - $296,917	9,700 New	9,700 $210,000
Q4 2019 Feb 14, 2020	SELL	$19.53 - $25.5 $193,347 - $252,450	-9,900 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $184,338 - $242,649	9,900 New	9,900 $214,000

Others Institutions Holding RYTM

# of Institutions

192

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

Primecap Management CO Pasadena, CA

7.22M
Shares

$406 Million
0.28% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$379 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.4M
Shares

$360 Million
3.59% of portfolio
Ra Capital Management, L.P. Boston, MA

6.08M
Shares

$342 Million
4.44% of portfolio
Goldman Sachs Group Inc New York, NY

3.88M
Shares

$218 Million
0.03% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account